These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms. Smith LA; Mckay CJ Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220 [TBL] [Abstract][Full Text] [Related]
63. Clinical Outcomes of Endoscopic Ultrasonography-Guided Pancreatic Cyst Ablation. Park JK; Song BJ; Ryu JK; Paik WH; Park JM; Kim J; Lee SH; Kim YT Pancreas; 2016 Jul; 45(6):889-94. PubMed ID: 26765962 [TBL] [Abstract][Full Text] [Related]
64. Imaging of pancreatic cystic lesions with confocal laser endomicroscopy: an ex vivo pilot study. Kadayifci A; Atar M; Yang M; Fernandez-Del Castillo C; Mino-Kenudson M; Brugge WR Surg Endosc; 2017 Dec; 31(12):5119-5126. PubMed ID: 28444494 [TBL] [Abstract][Full Text] [Related]
65. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010 [TBL] [Abstract][Full Text] [Related]
67. [Pancreatic tumor: progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN) mucinous cystic neoplasm (MCN); 4. Current therapies for IPMN and MCN]. Takaori K Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):74-8. PubMed ID: 22413464 [No Abstract] [Full Text] [Related]
68. Contrast-enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm. Del Vecchio Blanco G; Gesuale C; Anselmo A; Palmieri G; Baciorri F; Di Prete M; Tisone G; Monteleone G; Paoluzi OA Clin J Gastroenterol; 2020 Feb; 13(1):120-126. PubMed ID: 31280471 [TBL] [Abstract][Full Text] [Related]
69. European experts consensus statement on cystic tumours of the pancreas. Del Chiaro M; Verbeke C; Salvia R; Klöppel G; Werner J; McKay C; Friess H; Manfredi R; Van Cutsem E; Löhr M; Segersvärd R; Dig Liver Dis; 2013 Sep; 45(9):703-11. PubMed ID: 23415799 [TBL] [Abstract][Full Text] [Related]
70. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas. Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480 [TBL] [Abstract][Full Text] [Related]
71. Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas. Inagaki M; Obara M; Kino S; Goto J; Suzuki S; Ishizaki A; Tanno S; Kohgo Y; Tokusashi Y; Miyokawa N; Kasai S J Hepatobiliary Pancreat Surg; 2007; 14(3):264-9. PubMed ID: 17520201 [TBL] [Abstract][Full Text] [Related]
72. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm. Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913 [TBL] [Abstract][Full Text] [Related]
73. Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasms. Du C; Chai NL; Linghu EQ; Li HK; Sun LH; Jiang L; Wang XD; Tang P; Yang J World J Gastroenterol; 2017 May; 23(17):3184-3192. PubMed ID: 28533675 [TBL] [Abstract][Full Text] [Related]
74. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up. Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561 [TBL] [Abstract][Full Text] [Related]
75. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Pais SA; Attasaranya S; Leblanc JK; Sherman S; Schmidt CM; DeWitt J Clin Gastroenterol Hepatol; 2007 Apr; 5(4):489-95. PubMed ID: 17350894 [TBL] [Abstract][Full Text] [Related]
78. Approach to cystic lesions of the pancreas. Schmid RM; Siveke JT Wien Med Wochenschr; 2014 Feb; 164(3-4):44-50. PubMed ID: 24254128 [TBL] [Abstract][Full Text] [Related]
79. MRI findings of intraductal papillary mucinous neoplasms (IPMNs). Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864 [TBL] [Abstract][Full Text] [Related]
80. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms. Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]